메뉴 건너뛰기




Volumn 17, Issue 5, 2010, Pages 741-747

Antibody response patterns to Bordetella pertussis antigens in vaccinated (primed) and unvaccinated (unprimed) young children with pertussis

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; ANTIGEN; DIPHTHERIA PERTUSSIS TETANUS VACCINE; FILAMENTOUS HEMAGGLUTININ; FIMBRIA PROTEIN; HEMAGGLUTININ; PERTACTIN; PERTUSSIS TOXIN; UNCLASSIFIED DRUG;

EID: 77951983311     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00469-09     Document Type: Article
Times cited : (46)

References (26)
  • 1
    • 84920205236 scopus 로고
    • Placebo-controlled trial of two acellular pertussis vaccines in Sweden - Protective efficacy and adverse events
    • Ad Hoc Group for the Study of Pertussis Vaccines
    • Ad Hoc Group for the Study of Pertussis Vaccines. 1988. Placebo-controlled trial of two acellular pertussis vaccines in Sweden - protective efficacy and adverse events. Lancet i:955-960.
    • (1988) Lancet , vol.1 , pp. 955-960
  • 2
    • 0025362143 scopus 로고
    • Comparison of an acellular pertussis-component diphtheria-tetanus- pertussis (DTP) vaccine with a whole-cell pertussis-component DTP vaccine in 17- To 24-month-old children, with measurement of 69-kilodalton outer membrane protein antibody
    • Blumberg, D. A., C. M. Mink, J. D. Cherry, K. S. Reisinger, M. M. Blatter, B. L. Congeni, C. L. Dekker, M. G. Stout, J. R. Mezzatesta, J. V. Scott, et al. 1990. Comparison of an acellular pertussis-component diphtheria-tetanus-pertussis (DTP) vaccine with a whole-cell pertussis-component DTP vaccine in 17- to 24-month-old children, with measurement of 69-kilodalton outer membrane protein antibody. J. Pediatr. 117:46-51.
    • (1990) J. Pediatr. , vol.117 , pp. 46-51
    • Blumberg, D.A.1    Mink, C.M.2    Cherry, J.D.3    Reisinger, K.S.4    Blatter, M.M.5    Congeni, B.L.6    Dekker, C.L.7    Stout, M.G.8    Mezzatesta, J.R.9    Scott, J.V.10
  • 4
    • 1342301472 scopus 로고    scopus 로고
    • Determination of serum antibody to Bordetella pertussis adenylate cyclase toxin in vaccinated and unvaccinated children and in children and adults with pertussis
    • Cherry, J. D., D. X. L. Xing, P. Newland, K. Patel, U. Heininger, and M. J. Corbel. 2004. Determination of serum antibody to Bordetella pertussis adenylate cyclase toxin in vaccinated and unvaccinated children and in children and adults with pertussis. Clin. Infect. Dis. 38:502-507.
    • (2004) Clin. Infect. Dis. , vol.38 , pp. 502-507
    • Cherry, J.D.1    Xing, D.X.L.2    Newland, P.3    Patel, K.4    Heininger, U.5    Corbel, M.J.6
  • 5
    • 0032374233 scopus 로고    scopus 로고
    • A search for serologic correlates of immunity to Bordetella pertussis cough illnesses
    • Cherry, J. D., J. Gornbein, U. Heininger, and K. Stehr. 1998. A search for serologic correlates of immunity to Bordetella pertussis cough illnesses. Vaccine 16:1901-1906.
    • (1998) Vaccine , vol.16 , pp. 1901-1906
    • Cherry, J.D.1    Gornbein, J.2    Heininger, U.3    Stehr, K.4
  • 6
    • 0030058665 scopus 로고    scopus 로고
    • A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine
    • Gustafsson, L., H. O. Hallander, P. Olin, E. Reizenstein, and J. Storsaeter. 1996. A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine. N. Engl. J. Med. 334:349-355.
    • (1996) N. Engl. J. Med. , vol.334 , pp. 349-355
    • Gustafsson, L.1    Hallander, H.O.2    Olin, P.3    Reizenstein, E.4    Storsaeter, J.5
  • 7
    • 70350346399 scopus 로고    scopus 로고
    • Kinetics and sensitivity of ELISA IgG pertussis antitoxin after infection and vaccination with Bordetella pertussis in young children
    • Hallander, H. O., M. Ljungman, J. Storsaeter, and L. Gustafsson. 2009. Kinetics and sensitivity of ELISA IgG pertussis antitoxin after infection and vaccination with Bordetella pertussis in young children. APMIS 117:797-807.
    • (2009) APMIS , vol.117 , pp. 797-807
    • Hallander, H.O.1    Ljungman, M.2    Storsaeter, J.3    Gustafsson, L.4
  • 8
    • 69449095972 scopus 로고    scopus 로고
    • Should fimbriae be included in pertussis vaccines? Studies on ELISA IgG anti-Fim 2/3 antibodies after vaccination and infection
    • Hallander, H. O., M. Ljungman, M. Jahnmatz, J. Storsaeter, L. Nilsson, and L. Gustafsson. 2009. Should fimbriae be included in pertussis vaccines? Studies on ELISA IgG anti-Fim 2/3 antibodies after vaccination and infection. APMIS 117:660-671.
    • (2009) APMIS , vol.117 , pp. 660-671
    • Hallander, H.O.1    Ljungman, M.2    Jahnmatz, M.3    Storsaeter, J.4    Nilsson, L.5    Gustafsson, L.6
  • 9
    • 0031657944 scopus 로고    scopus 로고
    • Comparative efficacy of the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine and Lederle whole-cell component DTP vaccine in German children after household exposure
    • the Pertussis Vaccine Study Group
    • Heininger, U., J. D. Cherry, K. Stehr, S. Schmitt-Grohé, M. Uberall, S. Laussucq, T. Eckhardt, M. Meyer, J. Gornbein, and the Pertussis Vaccine Study Group. 1998. Comparative efficacy of the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine and Lederle whole-cell component DTP vaccine in German children after household exposure. Pediatrics 102:546-553.
    • (1998) Pediatrics , vol.102 , pp. 546-553
    • Heininger, U.1    Cherry, J.D.2    Stehr, K.3    Schmitt-Grohé, S.4    Uberall, M.5    Laussucq, S.6    Eckhardt, T.7    Meyer, M.8    Gornbein, J.9
  • 13
    • 0002943899 scopus 로고
    • Serologic response to Bordetella pertussis
    • N. R. Rose, H. Friedman, and J. L. Fahey (ed.), 3rd ed. American Society for Microbiology, Washington, DC
    • Manclark, C. R., B. D. Meade, and D. G. Burstyn. 1986. Serologic response to Bordetella pertussis, p. 388-394. In N. R. Rose, H. Friedman, and J. L. Fahey (ed.), Manual of clinical laboratory immunology, 3rd ed. American Society for Microbiology, Washington, DC.
    • (1986) Manual of Clinical Laboratory Immunology , pp. 388-394
    • Manclark, C.R.1    Meade, B.D.2    Burstyn, D.G.3
  • 14
    • 17444421538 scopus 로고    scopus 로고
    • Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies
    • DOI 10.1128/CMR.18.2.326-382.2005
    • Mattoo, S., and J. D. Cherry. 2005. Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin. Microbiol. Rev. 18:326-382. (Pubitemid 40548297)
    • (2005) Clinical Microbiology Reviews , vol.18 , Issue.2 , pp. 326-382
    • Mattoo, S.1    Cherry, J.D.2
  • 15
    • 0002417258 scopus 로고
    • Serodiagnosis of pertussis
    • C. R. Manclark (ed.), DHHS publication no. (FDA) 90-1164. Department of Health and Human Services, United States Public Health Service, Bethesda, MD
    • Meade, B. D., C. M. Mink, and C. R. Manclark. 1990. Serodiagnosis of pertussis, p. 322-329. In C. R. Manclark (ed.), Proceedings of the Sixth International Symposium on Pertussis. DHHS publication no. (FDA) 90-1164. Department of Health and Human Services, United States Public Health Service, Bethesda, MD.
    • (1990) Proceedings of the Sixth International Symposium on Pertussis , pp. 322-329
    • Meade, B.D.1    Mink, C.M.2    Manclark, C.R.3
  • 17
    • 0031590627 scopus 로고    scopus 로고
    • Randomised controlled trial of two-component, three-component, and five-component acellular pertussis vaccines compared with whole-cell pertussis vaccine
    • Ad Hoc Group for the Study of Pertussis Vaccines
    • Olin, P., F. Rasmussen, L. Gustafsson, H. O. Hallander, and H. Heijbel. 1997. Randomised controlled trial of two-component, three-component, and five-component acellular pertussis vaccines compared with whole-cell pertussis vaccine. Ad Hoc Group for the Study of Pertussis Vaccines. Lancet 350:1569-1577.
    • (1997) Lancet , vol.350 , pp. 1569-1577
    • Olin, P.1    Rasmussen, F.2    Gustafsson, L.3    Hallander, H.O.4    Heijbel, H.5
  • 21
    • 0031922315 scopus 로고    scopus 로고
    • Evaluation of an immunoglobulin G enzyme-linked immunosorbent assay for pertussis toxin and filamentous hemagglutinin in diagnosis of pertussis in Senegal
    • Simondon, F., I. Iteman, M. P. Preziosi, A. Yam, and N. Guiso. 1998. Evaluation of an immunoglobulin G enzyme-linked immunosorbent assay for pertussis toxin and filamentous hemagglutinin in diagnosis of pertussis in Senegal. Clin. Diagn. Lab. Immunol. 5:130-134.
    • (1998) Clin. Diagn. Lab. Immunol. , vol.5 , pp. 130-134
    • Simondon, F.1    Iteman, I.2    Preziosi, M.P.3    Yam, A.4    Guiso, N.5
  • 22
    • 6844258864 scopus 로고    scopus 로고
    • A comparative efficacy trial in germany in infants who received either the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine, the lederle whole-cell component DTP vaccine, or DT vaccine
    • DOI 10.1542/peds.101.1.1
    • Stehr, K., J. D. Cherry, U. Heininger, S. Schmitt-Grohe, M. Uberall, S. Laussucq, T. Eckhardt, M. Meyer, R. Engelhardt, and P. Christenson. 1998. A comparative efficacy trial in Germany in infants who received either the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine, the Lederle whole-cell component DTP vaccine, or DT vaccine. Pediatrics 101: 1-11. (Pubitemid 28030315)
    • (1998) Pediatrics , vol.101 , Issue.1 , pp. 1-11
    • Stehr, K.1    Cherry, J.D.2    Heininger, U.3    Schmitt-Grohe, S.4    Uberall, M.5    Laussucq, S.6    Eckhardt, T.7    Meyer, M.8    Engelhardt, R.9    Christenson, P.10
  • 23
    • 0009486355 scopus 로고
    • Evaluation of laboratory methods used for the diagnosis of pertussis infection and disease in the Swedish efficacy trial
    • C. R. Manclark (ed.), DHHS publication no. (FDA) 90-1164. Department of Health and Human Services, United States Public Health Service, Bethesda, MD
    • Storsaeter, J., H. O. Hallander, and C. P. Farrington. 1990. Evaluation of laboratory methods used for the diagnosis of pertussis infection and disease in the Swedish efficacy trial, p. 291-294. In C. R. Manclark (ed.), Proceedings of the Sixth International Symposium on Pertussis. DHHS publication no. (FDA) 90-1164. Department of Health and Human Services, United States Public Health Service, Bethesda, MD.
    • (1990) Proceedings of the Sixth International Symposium on Pertussis , pp. 291-294
    • Storsaeter, J.1    Hallander, H.O.2    Farrington, C.P.3
  • 24
    • 0032374254 scopus 로고    scopus 로고
    • Levels of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussis
    • DOI 10.1016/S0264-410X(98)00227-8, PII S0264410X98002278
    • Storsaeter, J., H. O. Hallander, L. Gustafsson, and P. Olin. 1998. Levels of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussis. Vaccine 16:1907-1916. (Pubitemid 28473934)
    • (1998) Vaccine , vol.16 , Issue.20 , pp. 1907-1916
    • Storsaeter, J.1    Hallander, H.O.2    Gustafsson, L.3    Olin, P.4
  • 25
    • 0034034605 scopus 로고    scopus 로고
    • Prolonged afebrile non-productive cough illnesses in American soldiers in Korea: A serologic search for causation
    • Vincent, J. M., J. D. Cherry, W. F. Nauschuetz, et al. 2000. Prolonged afebrile non-productive cough illnesses in American soldiers in Korea: a serologic search for causation. Clin. Infect. Dis. 30:534-539.
    • (2000) Clin. Infect. Dis. , vol.30 , pp. 534-539
    • Vincent, J.M.1    Cherry, J.D.2    Nauschuetz, W.F.3
  • 26
    • 0004349374 scopus 로고
    • MIM/EPI/PERT/91.1. WHO, Geneva, Switzerland
    • World Health Organization. 1991. WHO meeting on case definition of pertussis, Geneva, 10-11 January 1991, p. 4-5. MIM/EPI/PERT/91.1. WHO, Geneva, Switzerland. http://whqlibdoc.who.int/hq/1991/MIM-EPI-PERT-91.1.pdf.
    • (1991) WHO Meeting on Case Definition of Pertussis, Geneva, 10-11 January 1991 , pp. 4-5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.